ImmunityBio, Inc. Income Statement

Income Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.60M0.64M0.24M0.04M0.04M0.05M2.20M0.60M0.93M0.24M0.62M14.74M
Gross Profit 0.60M0.64M0.24M0.04M0.04M0.05M2.20M0.60M0.93M0.24M0.62M14.74M
Operating items
Amortization - Intangibles -0.04M-2.18M-1.60M-0.46M0.00M-0.86M
Research & Development 0.45M1.59M11.43M29.15M42.04M55.72M112.00M139.51M195.96M248.15M232.37M190.14M
Selling, General & Administrative 2.42M4.62M227.68M95.39M57.12M42.72M46.46M71.32M135.26M102.71M129.62M168.78M
Other Operating Expenses 10.66M0.68M0.89M
Operating Expenses 2.87M6.22M239.11M124.54M99.17M98.44M158.45M221.49M331.21M351.54M362.87M358.93M
Operating Income -2.27M-5.58M-238.88M-124.50M-99.12M-98.39M-156.25M-220.88M-330.28M-351.30M-362.25M-344.18M
EBIT -2.27M-5.58M-238.88M-124.50M-99.12M-98.39M-156.25M-220.88M-330.28M-351.30M-362.25M-344.18M
Non-operating items
Non Operating Investment Income 2.44M2.44M-4.10M-3.09M1.13M7.97M
Interest & Investment Income 0.00M0.02M2.99M5.17M4.22M2.32M1.64M1.23M
Other Non Operating Income 0.08M0.09M0.16M0.24M-0.53M1.49M0.19M-0.74M-2.22M13.48M
Non Operating Income -0.61M1.70M3.12M2.20M1.66M-4.01M-5.15M-19.56M-65.99M-221.64M-69.46M
Net income details
EBT -2.05M-6.18M-237.18M-121.38M-96.92M-96.73M-160.26M-226.03M-349.84M-417.29M-583.89M-413.64M
Tax Provisions 0.00M0.00M-0.30M-0.57M-0.49M-0.50M-0.10M-1.85M0.01M0.03M-0.04M
Profit After Tax -2.05M-6.18M-236.88M-120.81M-96.42M-96.23M-160.16M-224.19M-349.85M-417.32M-583.85M-413.64M
Equity Income -0.80M-12.11M-7.55M
Income from Non-Controlling Interests -2.38M-2.34M-3.06M-0.75M-0.66M-0.08M
Income from Continuing Operations -2.05M-6.18M-236.88M-120.81M-96.42M-96.23M-160.16M-224.19M-349.85M-417.32M-583.85M-413.64M
Consolidated Net Income -2.05M-6.18M-236.88M-120.81M-96.42M-96.23M-160.16M-224.19M-349.85M-417.32M-583.85M-413.64M
Income towards Parent Company -2.05M-6.18M-236.88M-120.81M-96.42M-96.23M-160.16M-224.19M-349.85M-417.32M-583.85M-413.64M
Net Income towards Common Stockholders -2.05M-6.18M-236.88M-120.81M-96.42M-96.23M-160.16M-224.19M-349.85M-417.32M-583.85M-413.64M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 76.96M81.22M82.38M79.46M79.23M98.37M108.59M397.59M400.30M667.71M696.83M
Shares Outstanding (Diluted Average) 366.32M377.07M389.23M399.90M508.64M700.44M
EBITDA -2.27M-5.58M-238.88M-124.50M-99.12M-98.39M-156.25M-220.88M-330.28M-351.30M-362.25M-344.18M
Tax Rate 0.13%0.47%0.51%0.52%0.07%0.82%0.01%